AI assistant
Organon & Co. — Director's Dealing 2026
Mar 3, 2026
31461_dirs_2026-03-03_29dac463-73ce-4ce0-ba47-408a167c5db4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2026-02-27
Reporting Person: Falcione Aaron (Chief Human Resources Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | Common Stock | A | 23805 | — | Acquired | 86778.661 | Direct |
| 2026-02-27 | Common Stock | F | 8705 | $7.17 | Disposed | 78073.661 | Direct |
| 2026-02-27 | Common Stock | A | 6717 | — | Acquired | 84790.661 | Direct |
| 2026-02-27 | Common Stock | F | 2301 | $7.23 | Disposed | 84109.071 | Direct |
Footnotes
F1: Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 11, 2023 under the Organon & Co. 2021
Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of
Directors.
F2: Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
F3: Includes the addition of 1,619.41 shares of Common Stock acquired from dividend equivalents net of withholding tax not previously required to be reported.